UPDATE: Wells Fargo Downgrades CRISPR Therapeutics (CRSP) to Equal Weight
Tweet Send to a Friend
(Updated - December 7, 2020 6:05 AM EST)
(updating comment)Wells Fargo analyst Jim Birchenough downgraded CRISPR Therapeutics (NASDAQ: CRSP) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Wells Fargo analyst Jim Birchenough downgraded CRISPR Therapeutics (NASDAQ: CRSP) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
